학술논문

Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+tumors: Focus on Asian pts
Document Type
Journal
Source
ANNALS OF ONCOLOGY; NOV 2023, 34 pS1495-pS1495, 1p. Supplement: 4
Subject
Language
English
ISSN
15698041